[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmacology and Phase 3 clinical efficacy and safety trials for the treatment of ADHD in children, adolescents, and adults; and CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and related disorders. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.99, "open": 4.02, "dayLow": 3.975, "dayHigh": 4.19, "regularMarketPreviousClose": 3.99, "regularMarketOpen": 4.02, "regularMarketDayLow": 3.975, "regularMarketDayHigh": 4.19, "payoutRatio": 0.0, "beta": -0.752, "trailingPE": 0.03103244, "forwardPE": -0.5731874, "volume": 131394, "regularMarketVolume": 131394, "averageVolume": 130927, "averageVolume10days": 180640, "averageDailyVolume10Day": 180640, "bid": 2.97, "ask": 5.12, "bidSize": 2, "askSize": 2, "marketCap": 22058842, "fiftyTwoWeekLow": 3.02, "fiftyTwoWeekHigh": 11.88, "fiftyDayAverage": 4.543, "twoHundredDayAverage": 4.30995, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 20359984, "profitMargins": 0.0, "floatShares": 5404512, "sharesOutstanding": 5264640, "sharesShort": 225531, "sharesShortPriorMonth": 194876, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0438, "heldPercentInsiders": 0.01878, "heldPercentInstitutions": 0.05454, "shortRatio": 2.06, "shortPercentOfFloat": 0.0448, "impliedSharesOutstanding": 5146240, "bookValue": 1.127, "priceToBook": 3.7178352, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -17955008, "trailingEps": 135.02, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -1.183, "52WeekChange": -0.5920156, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 4.19, "targetHighPrice": 62.0, "targetLowPrice": 8.0, "targetMeanPrice": 27.71333, "targetMedianPrice": 20.64, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 8900183, "totalCashPerShare": 1.644, "ebitda": -17208596, "totalDebt": 6581695, "quickRatio": 1.329, "currentRatio": 1.518, "debtToEquity": 119.409, "returnOnAssets": -1.19968, "returnOnEquity": -4.1777, "grossProfits": -10680752, "freeCashflow": -9104629, "operatingCashflow": -17366526, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "corporateActions": [], "postMarketTime": 1755904854, "regularMarketTime": 1755892801, "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "postMarketChangePercent": -4.057281, "postMarketPrice": 4.02, "postMarketChange": -0.17000008, "regularMarketChange": 0.2, "regularMarketDayRange": "3.975 - 4.19", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 130927, "fiftyTwoWeekLowChange": 1.1700001, "fiftyTwoWeekLowChangePercent": 0.38741726, "fiftyTwoWeekRange": "3.02 - 11.88", "fiftyTwoWeekHighChange": -7.69, "fiftyTwoWeekHighChangePercent": -0.6473064, "fiftyTwoWeekChangePercent": -59.20156, "regularMarketChangePercent": 5.01253, "regularMarketPrice": 4.19, "epsTrailingTwelveMonths": 135.02, "epsForward": -7.31, "epsCurrentYear": -3.75667, "priceEpsCurrentYear": -1.1153495, "fiftyDayAverageChange": -0.35300016, "fiftyDayAverageChangePercent": -0.07770199, "twoHundredDayAverageChange": -0.11994982, "twoHundredDayAverageChangePercent": -0.027830908, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "displayName": "Cingulate", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]